ABIRATERONE - TRIMA 250 MG

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
07-08-2023

Bahan aktif:

ABIRATERONE ACETATE

Boleh didapati daripada:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

Kod ATC:

L02BX03

Borang farmaseutikal:

TABLETS

Komposisi:

ABIRATERONE ACETATE 250 MG

Laluan pentadbiran:

PER OS

Jenis preskripsi:

Required

Dikeluarkan oleh:

DR. REDDY'S LABORATORIES LIMITED, INDIA

Kawasan terapeutik:

ABIRATERONE

Tanda-tanda terapeutik:

Abiraterone Trima 250 mg is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. The treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).

Tarikh kebenaran:

2023-03-19

Risalah maklumat

                                PATIENT LEAFLET IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s prescription only
Abiraterone - Trima 250 mg
Tablets
Active ingredient and its quantity
abiraterone acetate 250 mg
Inactive ingredients and allergens in the preparation – see section
2 under
“Important information about some of the ingredients of the
medicine”, and
section 6 “Further Information”.
Read the leaflet carefully in its entirety before using the medicine.
This
leaflet contains concise information about the medicine. If you have
further
questions, refer to the doctor or pharmacist.
This medicine has been prescribed for the treatment of your ailment.
Do not pass it on to others. It may harm them even if it seems to you
that
their ailment is similar to yours.
1. WHAT IS THE MEDICINE INTENDED FOR?
Abiraterone - Trima 250 mg is given in combination with prednisone for
the
treatment of:
metastatic castration-resistant prostate cancer.
adult males with newly diagnosed high risk metastatic
hormone-sensitive
prostate cancer )mHSPC( in combination with androgen deprivation
therapy )ADT(.
Therapeutic group:
Specific inhibitor of the enzyme CYP17.
2. BEFORE USING THE MEDICINE
Do not use the medicine:
If you are sensitive )allergic( to abiraterone acetate or to any of
the
additional ingredients contained in the medicine. For a list of the
additional ingredients, see section 6 “Further Information”.
If you are a woman, and especially a pregnant woman.
Abiraterone - Trima 250 mg is intended for use in males only.
If you suffer from severe liver damage.
In combination with Ra-223 )used to treat prostate cancer(.
Do not take the medicine if any of the above points apply to your
condition.
If you are not sure, consult with your doctor or pharmacist before
taking the
medicine.
Special warnings regarding use of the medicine
BEFORE TREATMENT WITH ABIRATERONE - TRIMA 250 MG, TALK TO THE DOCTOR:
- If you suffer from liver problems
- If you suffer from high blood pressure, heart f
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Arab 07-08-2023
Risalah maklumat Risalah maklumat Ibrani 07-08-2023

Cari amaran yang berkaitan dengan produk ini